InvestorsHub Logo
Followers 85
Posts 6176
Boards Moderated 0
Alias Born 05/27/2009

Re: None

Tuesday, 03/23/2021 9:49:35 AM

Tuesday, March 23, 2021 9:49:35 AM

Post# of 182
GRAY's Fred Guerard named in Top 25 BioTech CEOs 2021...

24. Frederic Guerard - Company: Graybug Vision - Title: Chief Executive Officer.

"Frederic Guerard is the Chief Executive Officer of Graybug Vision, a company that develops transformative medicines for ocular diseases of the retina and optic nerve. Headquartered in Redwood City, California, Graybug's proprietary ocular delivery technologies are designed to maintain effective drug levels in ocular tissue for six months and potentially longer, improving disease management, reducing healthcare burdens, and ultimately delivering better clinical outcomes for patients with vision-threatening diseases, such as wet age-related macular degeneration.

Guerard has served as CEO of Graybug since 2019 and led the planning and successful execution of the company's IPO in September 2020. With over two decades of experience in the pharmaceutical industry, Guerard helped Graybug raise over $150 million between Series C funding and its IPO. Prior to Graybug, Guerard spent twenty years of his career at Novartis, where he most recently held the position of Worldwide Business Franchise Head Ophthalmology, among numerous leadership roles in the company. He also served on the Board of the Association of the British Pharmaceutical Industry and on the Board of Medicines Australia. Guerard holds a Doctorate of Pharmacy and a Master of Biological and Medical Sciences degree from the University of Rouen, France, as well as a Master of Marketing degree from the international business school HEC, Paris."


GLTA
.
.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GRAY News